12 hrs ago | Daily Record
Scots airports and stations to get defibrilators in bid to battle heart attack deaths
SAVING defibrillators could be installed at airports and railway stations to cut deaths from heart attacks.
Survivors shed stroke myths and issue warnings
Hana Ascano is a lively young woman who was among many who believed that strokes only affect older people.
Study Supports Wider Use of Statins
An analysis of studies supports a growing belief that guidelines for prescribing cholesterol-lowering statin drugs should be expanded to include healthy people without established heart disease, cardiologists say.
By COSHANDRA DILLARD Staff Writer A pair of Trinity Mother Frances Hospitals and Clinics nurses is reminding East Texans to be watchful of the signs of stroke, particularly those at a higher risk.
A temporary interruption of blood supply to part of the brain, also known as a ministroke.
Bruno Cafiso is alive today because his wife, Bonna, recognized the early warning signs of a stroke.
New Tool Finds Best Heart Disease and Stroke Treatments For Patients That Have Diabetes
Researchers from North Carolina State University and Mayo Clinic have developed a computer model that medical doctors can use to determine the best time to begin using statin therapy in diabetes patients to help prevent heart disease and stroke.
Action plan to cut sudden death
Defibrillator machines could be installed at airports and railway stations in a bid to cut heart deaths.
Friendly advice abounds at Cape Coral Hospital stroke support group
Phylis Rollins, 56, of Cape Coral, had severe headaches. Al Palmer, 62, of Cape Coral, drove his car and couldn't keep his left foot on the clutch.
Central heat wave blamed for at least 4 deaths
A steady heat wave across the central U.S. is blamed for four deaths and suspected to have factored in two others from Chicago to Texas, officials said Friday.
Migraine Pattern Linked to Heart Attack Risk
Women with a certain pattern of migraine headaches may be more likely to have a heart attack, a study has found.
CytRx to Present Statistically Significant Evidence of Arimoclomol's...
CytRx Corporation , a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced that an experimental animal trial produced statistically significant evidence that the company's chaperone amplifying drug candidate arimoclomol provided protection from the detrimental cognitive and sensorimotor ...
Canada's heart attack death rates decline rapidly
Deaths and hospital admissions from cardiovascular disease dropped almost 30 per cent in the decade after 1994, but slightly more women than men were dying from cardiovascular causes, Canadian researchers say.
Researchers want to study people who suffered mild strokes
A three-year $600,000 project aimed at reducing the stroke risk factors in patients who have already had a mild or non-disabling stroke will be looking for 120 Cape Bretoners to participate in the study beginning this fall.
Heart disease deaths down by 30 per cent, but no time for complacency: study
Deaths from cardiovascular disease have dropped by almost a third in Canada, but for the first time slightly more women than men are dying from the country's Number 1 killer, statistics show.
Stroke risk jumps with irregular heartbeat
June 19, 2009 04:10 PM - People who have irregular heart rhythm, known as atrial fibrillation , are at five times the risk of having a stroke, says a well-known neurologist from the Trillium Health Centre .
Health Column: All about stroke
Stroke is the fourth leading cause of death and is the leading cause of disability in Canada.
Telemedicine can help patients avert disability
As he drove west along I-94 in Jefferson County, Michael Harrigan reached for his bottle of water, but he couldn't grip it.
The Laurinburg Exchange Online
"I feel a sense of sadness and joy. Mostly sadness though about what I've experienced and sadness about what others have experienced in reference to the stroke." - Luther Vandross May kicked off National Stroke Prevention Month.
New Anticoagulant Pill Works Well in Trial
The new anti-clotting pill rivaroxaban lowers the risk of stroke, heart attack and death in patients who have had a heart attack or suffer from unstable angina, a new trial shows.